Cargando…
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity
Chronic graft versus host disease (cGVHD) remains a major cause of non-relapse morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Currently there are no accepted measures of cGVHD activity to aid in clinical management and disease staging. We analyzed clinical markers...
Autores principales: | Grkovic, Lana, Baird, Kristin, Steinberg, Seth M., Williams, Kirsten M., Pulanic, Drazen, Cowen, Edward W., Mitchell, Sandra A., Hakim, Fran T., Martires, Kathryn J., Avila, Daniele N., Taylor, Tiffani N., Salit, Rachel B., Rowley, Scott D., Zhang, Dan, Fowler, Daniel H., Bishop, Michael R., Gress, Ronald E., Pavletic, Steven Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262945/ https://www.ncbi.nlm.nih.gov/pubmed/22005783 http://dx.doi.org/10.1038/leu.2011.254 |
Ejemplares similares
-
Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study
por: Prenc, Ema, et al.
Publicado: (2021) -
Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease
por: Katić, Mašenjka, et al.
Publicado: (2016) -
Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters
por: Vukić, Tamara, et al.
Publicado: (2016) -
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease
por: Zelic Kerep, Ana, et al.
Publicado: (2022) -
Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016)